LLY
Eli Lilly$750.77
LLY info-0.12%ย โ€ข 24 H
Dividend Yield:0.5%
Global Rank#10
Market Cap$713.37B
YTD Performance29.35%
P/E114.23
Revenue$28.54B
Change 7d-0.07%
SP500 BenchmarkOutperform
P/S24.99
Earnings$6.24B

Eli Lilly (LLY) Stock Overview

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

LLY Stock Information

SymbolLLY
Address
Lilly Corporate CenterIndianapolis, IN 46285United States
Founded-
Trading hours9:30 AM - 4:00 PM ET
Websitehttps://www.lilly.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number317 276 2000

Eli Lilly (LLY) Price Chart

-
Value:-

Eli Lilly Overview: Key Details and Summary

Stock data
2022
Change
Price
$750.77
N/A
Market Cap
$713.37B
N/A
Shares Outstanding
950.18M
-0.36%
Employees
39.00K
N/A
Shareholder Equity
10.78B
17.70%
Valuation
2022
Change
P/E Ratio
114.23
N/A
P/S Ratio
24.99
N/A
P/B Ratio
66.20
N/A
P/FCF
155.07
N/A
POE
0.00
N/A
Dividends
2022
Change
Dividend Yield
0.50%
N/A
Dividend per share
3.7212
N/A
Dividend Payout Ratio
0.5662
N/A
Growth
2022
Change
ROIC
0.1454
N/A
CAPEX
-1.85B
N/A
Return on Equity
0.5795
N/A
Earnings
2022
Change
Revenue
$28.54B
N/A
Earnings
$6.24B
N/A
Free Cash Flow
$4.60B
N/A
EPS
6.57
N/A
Earnings Yield
0.0088
N/A
Gross Margin
0.7677
N/A
Operating Margin
0.3032
N/A
Net income margin
0.2188
N/A
FCF Margin
0.1612
N/A
Financial Strength
2022
Change
Total Assets
$49.49B
N/A
Total Debt
$16.24B
N/A
Cash on Hand
$2.21B
N/A
Debt to Equity
$3.59
-17.05%
Cash to Debt
0.1362
-41.16%
POE
0.0000
N/A
Current Ratio
$1.05
-14.16%
Other data
2022
Change
Buyback Yield
0.0021
N/A
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon